Doctor Nadia Bouabdallaoui
Montreal Heart Institute, Montreal (Canada)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/880x255/9cd18bf278/acvc-acronym-text-rgb.png)
Impact of time-to-treatment initiation of colchicine on cardiovascular outcomes after myocardial infarction: insights from the Colchicine Cardiovascular Outcomes Trial (COLCOT)
Event: ESC Congress 2020
Topic: Pharmacotherapy
Session: Impact of Colchicine on Cardiovascular Disease
ESC 365 is supported by
